We are live on ! Find out more
CC

Callan Capital Portfolio holdings

AUM $1.35B
1-Year Est. Return 8.35%
This Fund
S&P 500
This Quarter Est. Return
-3.38%
1 Year Est. Return
+8.35%
3 Year Est. Return
+20.11%
5 Year Est. Return
+98.58%
10 Year Est. Return
+95.87%
AUM
$934M
AUM Growth
+$29.8M
Cap. Flow
+$64.1M
Cap. Flow %
6.87%
Top 10 Hldgs %
51.09%
Holding
212
New
29
Increased
119
Reduced
37
Closed
8
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TLTD icon
176
Northern Trust Morningstar Developed Markets ex-US Factor Tilt ETF
TLTD
$690M
$240K 0.03%
3,835
+12
+0.3% +$780
VLO icon
177
Valero Energy
VLO
$101B
$240K 0.03%
+1,692
New +$222K
MRTX
178
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$237K 0.03%
+5,431
New +$194K
VUG icon
179
Vanguard Morningstar Growth ETF
VUG
$228B
$231K 0.02%
+5,100
New +$241K
IG icon
180
Principal Investment Grade Corporate Active ETF
IG
$202M
$231K 0.02%
11,762
DIA icon
181
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$46B
$226K 0.02%
+675
New +$234K
AVIV icon
182
Avantis International Large Cap Value ETF
AVIV
$2.11B
$224K 0.02%
+4,658
New +$228K
PYPL icon
183
PayPal
PYPL
$45.9B
$219K 0.02%
3,745
+191
+5% +$12.4K
XBI icon
184
State Street SPDR S&P Biotech ETF
XBI
$11.3B
$215K 0.02%
2,940
-195
-6% -$15.6K
AMD icon
185
Advanced Micro Devices
AMD
$760B
$214K 0.02%
+2,079
New +$226K
PXH icon
186
Invesco FTSE RAFI Emerging Markets ETF
PXH
$2.01B
$214K 0.02%
11,986
PXD
187
DELISTED
Pioneer Natural Resource Co.
PXD
$209K 0.02%
+911
New +$207K
ED icon
188
Consolidated Edison
ED
$39.8B
$207K 0.02%
+2,421
New +$221K
RSPT icon
189
Invesco S&P 500 Equal Weight Technology ETF
RSPT
$5.89B
$204K 0.02%
+7,240
New +$211K
SHEL icon
190
Shell
SHEL
$250B
$202K 0.02%
+3,143
New +$196K
OBDC icon
191
Blue Owl Capital
OBDC
$5.57B
$197K 0.02%
+14,237
New +$197K
PSTX
192
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$182K 0.02%
76,559
+4,000
+6% +$8.38K
KYN icon
193
Kayne Anderson Energy Infrastructure Fund
KYN
$2.51B
$143K 0.02%
17,027
DB icon
194
Deutsche Bank
DB
$75.8B
$118K 0.01%
+10,759
New +$116K
INGN icon
195
Inogen
INGN
$146M
$108K 0.01%
20,611
CDTX
196
DELISTED
Cidara Therapeutics
CDTX
$97.5K 0.01%
5,173
EQ icon
197
Equillium
EQ
$152M
$76.7K 0.01%
103,688
ALLO icon
198
Allogene Therapeutics
ALLO
$698M
$60.9K 0.01%
19,224
CRDF icon
199
Cardiff Oncology
CRDF
$73.1M
$43.3K ﹤0.01%
31,147
+17,560
+129% +$29.6K
USBC
200
USBC Inc
USBC
$165M
$42.5K ﹤0.01%
4,250
+500
+13% +$15K

Similar funds

Callan Capital's Q3 2023 Portfolio in Review

As of Q3 2023, Callan Capital held 212 positions worth $934M, up 3.3% from $904M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Callan Capital deployed $64.1M of net new capital in Q3 2023, opening 29 new positions and adding to 119 existing holdings. Its largest new stake was Fortinet: 52,261 shares worth $3.07M.

By sector, the portfolio is most concentrated in Miscellaneous at 90% of assets, down from 91% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Goldman Sachs ActiveBeta US Large Cap Equity ETF, an estimated $1.29M trimmed.

  • Callan Capital's largest Q3 2023 buy was Fortinet: 52,261 shares worth $3.07M.
  • Callan Capital added most to Schwab Fundamental US Large Company Index ETF in Q3 2023, an estimated $8.96M increase.
  • Callan Capital's biggest Q3 2023 reduction was Goldman Sachs ActiveBeta US Large Cap Equity ETF, cutting an estimated $1.29M.
  • Callan Capital fully exited Vanguard Short-Term Corporate Bond ETF in Q3 2023, selling an estimated $1.85M.
  • Callan Capital's ten largest holdings make up 51% of its $934M portfolio in Q3 2023.
  • Callan Capital opened 29 new positions and closed 8 in Q3 2023.
  • Callan Capital's portfolio value rose 3.3% quarter-over-quarter to $934M.

Based on Callan Capital's 13F filing for Q3 2023, filed 6 Nov 2023.